Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Johnson and Johnson | 20 |
| 2 | Scripps Research Institute | 5 |
| 3 | JNC Corp | 4 |
| 4 | L'Oréal SA | 4 |
| 5 | Novartis AG | 4 |
| 6 | Medtronic PLC | 2 |
| 7 | City of Hope | 1 |
| 8 | State University System of Florida | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 37 |
| 2 | A61P | Therapeutic activity (drug indications) | 36 |
| 3 | C07D | Heterocyclic compounds | 29 |
| 4 | A61Q | Cosmetics, personal care | 4 |
| 5 | G01N | Investigating / analysing materials | 4 |
| 6 | C07K | Peptides | 3 |
| 7 | A61M | Devices for introducing media into the body | 2 |
| 8 | Y02A | Climate change adaptation | 2 |
| 9 | C07B | General methods of organic chemistry | 1 |
| 10 | Y10T | Cross-reference (technical subjects) | 1 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Preparation for the application of agents in mini-droplets | 2000 | 311 | |
| DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | 2012 | Scripps Research Institute | 28 |
| Preparation for drug application in minute droplet form | 1992 | 64 | |
| NOVEL USE OF STABLE ISOTOPE LABELED L-TRYPTOPHAN | 2014 | Johnson and Johnson | 17 |
| HAIR DYEING PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE INDOLE OR INDOLINE COMPOUND, A METAL SALT, HYDROGEN PEROXIDE AND A BASIFYING AGENT | 2011 | L'Oréal SA | 19 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 2 |
| 2020 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Leif Wiklund | Lund University | 10 |
| 2 | Anders Björklund | Lund University | 9 |
| 3 | Ryszard Szkilnik | Silesian Center for Heart Disease | 7 |
| 4 | Odd‐Geir Berge | University of Bergen | 6 |
| 5 | H. Schloßberger | Max Planck Institute of Biochemistry | 5 |
| 6 | Geoffrey A. Head | Baker Heart and Diabetes Institute | 5 |
| 7 | Ole Bernt Fasmer | University of Bergen | 5 |
| 8 | R Brus | 5 | |
| 9 | Michele O. Carruba | University of Milan | 5 |
| 10 | Kjell Hole | University of Bergen | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Serotonin neurons of the midbrain raphe: Ascending projections | 1978 | 802 | Neurotransmitter Receptor Influence on Behavior |
| Release of substance P from the cat spinal cord. | 1987 | 371 | Anesthesia and Pain Management |
| The interplexiform cell system - I. Synapses of the dopaminergic neurons of the goldfish retina | 1978 | 355 | Neuroscience and Neuropharmacology Research |
| Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; Their roles in local alterations of cerebrospinal fluid and vasomotor activity | 1976 | 325 | Neuroscience and Neuropharmacology Research |
| Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat | 1975 | 317 | Neurotransmitter Receptor Influence on Behavior |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of 3-(2-aminoethyl)-1H-indole-5,6-diol?
Which organizations hold the most patents related to this compound?
What are the main patent classification areas for inventions involving this compound?
Who are the most prolific authors publishing research on this compound?
What is the historical patent filing trend for this compound?